The comparison of anticonvulsant properties of commercial diphenylhydantoin (DPH) and its 3-amino-derivative (3-amino-DPH).
Kozicka
M
M
Zakład Farmakologii, Akademia Medyczna w Lublinie.
D000284:Administration, Oral; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000633:toxicity; D001640:Bicuculline / Q000037:antagonists & inhibitors; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D051379:Mice; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010672:Phenytoin / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000633:toxicity; D011597:Psychomotor Performance / Q000187:drug effects; D013331:Strychnine / Q000037:antagonists & inhibitors
D000927:Anticonvulsants; C033362:N-aminodiphenylhydantoin; D010672:Phenytoin; D013331:Strychnine; D010433:Pentylenetetrazole; D001640:Bicuculline